• Home
  • News
  • Contact
  • #BIOPORT2022
BioportBioport
  • Schedule
  • Sponsors
  • Speakers
  • BioInnovation Challenge
  • Register
  • No menu assigned!

Janssen

  • 0 Shares Share
    0
  • 0

Janssen Inc., a pharmaceutical company of Johnson & Johnson, has been an innovator in the Canadian healthcare industry for over 50 years. We are guided by Our Credo, where our first responsibility is to the doctors, nurses and patients, and mothers and fathers, and all others who use our products and services. Our ultimate goal is to help people live healthy lives.

Janssen’s history and our values provide the focus for our contributions to healthcare today and in the future. This focus was best summarized by our company’s namesake, Dr. Paul Janssen when he said:

“There are still many diseases for which there is no cure, and effective drugs must be found. Although we have contributed to the solutions for some of these problems, we will continue our research efforts, because so much more needs to be done.”

Visit their website to learn more.

  • Previous Project
  • Next Project

CONFERENCE HOST: BIONOVA

#46 1344 Summer Street
Halifax, Nova Scotia
Canada B3H 0A8
Phone: 902-421-5705
Fax: 902-421-2733
Email: [email protected]

Recent News

  • NEWS RELEASE: BioNova Selects Eight Semi-Finalists to Participate in the 12th Annual BioInnovation Challenge August 25, 2022
  • Calling all Early-Stage Health and Life Sciences Companies in Atlantic Canada!  July 5, 2022
  • NEWS RELEASE: BioNova Announces MycoFutures North Atlantic as the Winner of the Eleventh Annual BioInnovation Challenge (BIC) at BioPort 2021 November 8, 2021
  • NEWS RELEASE: BioNova Selects Eight Semi-Finalists to Participate in the 11th Annual BioInnovation Challenge August 24, 2021
  • NEWS RELEASE: BioNova to Host the 20th Annual Regional BioPort Conference to Highlight the Innovation and Growth Potential of Health and Life Sciences July 12, 2021

Twitter

© 2016 BioNova

  • Home
  • Schedule
  • Sponsors
  • Speakers
  • BioInnovation Challenge
  • Register
  • News – Original
  • Contact